Cardiorenal syndrome (CRS) commonly occurs during treatment of acute decompensated ... or dysfunction of heart and kidney Sepsis, noncardiogenic shock AHF-ACS: Acute heart failure-acute coronary ...

The Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial randomly assigned 302 patients with predominant left ventricular failure following an acute ...

allowing their usage in paediatric patients with acute decompensated heart failure (ADHF) and cardiogenic shock. The amendment of PMA specifies the use of the devices for paediatric patients who ...

Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, ...

Johnson & Johnson today announced the FDA has expanded its approval of Impella heart pumps to treat specific pediatric ...

Patients that show symptoms of decompensated heart failure (DHF) require immediate medical attention to take the strain off heart muscles. Failing to get treatment could worsen the condition.

Reprieve Cardiovascular, Inc., a development-stage company focused on advancing acute decompensated heart failure (ADHF) treatment, today announced the first-in-human results of the Reprieve System at ...

for use in specific pediatric patients with symptomatic acute decompensated heart failure (ADHF) and cardiogenic shock. A PMA is the highest level of approval granted by the FDA for the safety and ...

decompensated heart failure, cardiogenic shock, pulmonary hypertension, or hypersensitivity reactions. Rapiblyk is supplied as a lyophilized powder containing 280mg of landiolol (equivalent to ...